Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairment.
Gallant
Michel
M
Merck Frosst Centre for Therapeutic Research, Kirkland, Québec, Canada H9H3L1. michel_gallant@merck.com
Aspiotis
Renee
R
Day
Stephen
S
Dias
Rebecca
R
Dubé
Daniel
D
Dubé
Laurence
L
Friesen
Richard W
RW
Girard
Mario
M
Guay
Daniel
D
Hamel
Pierre
P
Huang
Zheng
Z
Lacombe
Patrick
P
Laliberté
Sebastien
S
Lévesque
Jean-François
JF
Liu
Susana
S
Macdonald
Dwight
D
Mancini
Joseph
J
Nicholson
Donald W
DW
Styhler
Angela
A
Townson
Karen
K
Waters
Kerry
K
Young
Robert N
RN
Girard
Yves
Y